“Anlotinib Monotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter Case-Series Analysis: Anlotinib in NPC”. 2025. Radiology and Oncology 59 (4): 617-23. https://www.radioloncol.com/index.php/ro/article/view/4451.